tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DYN Stock Latest News

Dyne Therapeutics Reveals Q3 Results and Trial Updates
Company AnnouncementsDyne Therapeutics Reveals Q3 Results and Trial Updates
8d ago
DYN
Dyne Therapeutics reports Q3 EPS (96c), consensus (71c)
PremiumThe Fly
Dyne Therapeutics reports Q3 EPS (96c), consensus (71c)
10d ago
DYN
Verizon downgraded, Canadian Pacific upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Verizon downgraded, Canadian Pacific upgraded: Wall Street’s top analyst calls
29d ago
CP
RF
Dyne Therapeutics downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Dyne Therapeutics downgraded to Neutral from Overweight at JPMorgan
29d ago
DYN
Dyne Therapeutics presents data highlighting FORCE platform
PremiumThe Fly
Dyne Therapeutics presents data highlighting FORCE platform
1M ago
DYN
Dyne Therapeutics management to meet with Piper Sandler
PremiumThe FlyDyne Therapeutics management to meet with Piper Sandler
2M ago
DYN
Piper says buy Dyne ahead of ACHIEVE/DELIVER data, registrational cohorts
Premium
The Fly
Piper says buy Dyne ahead of ACHIEVE/DELIVER data, registrational cohorts
2M ago
DYN
Dyne Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
Dyne Therapeutics participates in a conference call with JPMorgan
2M ago
DYN
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
PremiumThe Fly
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
3M ago
H
T
Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’
PremiumThe Fly
Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’
3M ago
DYN
Stifel views pullback in Dyne Therapeutics shares as buying opportunity
PremiumThe Fly
Stifel views pullback in Dyne Therapeutics shares as buying opportunity
3M ago
DYN
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
PremiumThe Fly
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
3M ago
U
X
Dyne Therapeutics: Executive Shifts and Promising Clinical Trials
PremiumCompany AnnouncementsDyne Therapeutics: Executive Shifts and Promising Clinical Trials
3M ago
8K
DYN
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
Premium
The Fly
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
3M ago
DYN
Dyne Therapeutics announces leadership announcements
Premium
The Fly
Dyne Therapeutics announces leadership announcements
3M ago
DYN
Dyne Therapeutics price target raised to $66 from $41 at Stifel
PremiumThe Fly
Dyne Therapeutics price target raised to $66 from $41 at Stifel
3M ago
DYN
Dyne Therapeutics price target raised to $52 from $48 at Morgan Stanley
PremiumThe Fly
Dyne Therapeutics price target raised to $52 from $48 at Morgan Stanley
3M ago
DYN
Dyne Therapeutics price target raised to $53 from $43 at Piper Sandler
PremiumThe Fly
Dyne Therapeutics price target raised to $53 from $43 at Piper Sandler
3M ago
DYN
Dyne Therapeutics price target raised to $55 from $48 at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics price target raised to $55 from $48 at H.C. Wainwright
3M ago
DYN
Dyne Therapeutics price target raised to $50 from $42 at Chardan
PremiumThe FlyDyne Therapeutics price target raised to $50 from $42 at Chardan
3M ago
DYN
Dyne Therapeutics reports Q2 EPS (70c), consensus (72c)
Premium
The Fly
Dyne Therapeutics reports Q2 EPS (70c), consensus (72c)
3M ago
DYN
Dyne Therapeutics price target raised to $43 from $39 at JPMorgan
Premium
The Fly
Dyne Therapeutics price target raised to $43 from $39 at JPMorgan
5M ago
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >